knowledge -WSS

knowledge

author：comprehensive 2025-10-01 17:21:11 - browse：31843

Kidney transplants are the most common organ transplant procedure in the U.S., with 25,000 taking place in 2022. But for patients who receive new kidneys, the transplant is often followed by severe lifelong challenges, many of which are linked to the immunosuppression drug regimen required after surgery to ensure the body does not reject the new organ. These treatments have side effects and toxicities that impact patients’ long-term health, and even survival, leading to a transplant failure rate of 30-50% at the 10-year mark.

Now a new trial sponsored by Medeor Therapeutics, the results of which were presented Thursday at the American Society of Nephrology (ASN) Kidney Week 2023 Annual Meeting, offers hope that stem cell therapy may help patients discontinue their immunosuppressant regime within a year of the transplant.

“The ability to get a transplant without being on lifelong immunosuppression is kind of a dream in transplant, so I can see why this would generate a lot of excitement,” said Sommer Gentry, a professor of surgery at New York University, who was not involved in the study and was not at the actual presentation, but reviewed the trial’s presentation slides.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： How to ethically and practically extend health care to all

focus

WSS

The debate over Covid

One Duchenne patient's bittersweet hope for new treatment

Tornado touches down near Chicago's O'Hare airport amid extreme weather nationwide

Alnylam reports growth in sales of rare disease treatments

Late stage cancers on the rise after pandemic delayed screenings

Personalized medicine goes far beyond genetics

hotspot

knowledge

entertainment

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

China sends large group of warplanes, navy ships towards Taiwan in forceful display

In age of alternative facts, a scholarly course on calling out crap

How to ethically and practically extend health care to all

Virginia high school admissions case could be legal follow

Group behind ProMed defends move to subscription

After affirmative action ruling, medical educators look to 'holistic review'

When waiting feels immoral: Empathy in the emergency department

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

The debate over Covid

hotspot

Watch the official trailer for 'Ahsoka' series

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

2 officers injured in shooting in Orlando, police say

Medicare slashes safety net hospital payments by nearly $1 billion

Heart disease in astronauts blamed on cosmic radiation

explore

focus

hotspot

focus